M J Noordzij1, J D Lefrandt, R Graaff, A J Smit. 1. Division of Vascular Medicine, Department of Internal Medicine, University Medical Center, Groningen, The Netherlands. m.j.noordzij@int.umcg.nl
Abstract
BACKGROUND: Accumulation of advanced glycation end products (AGEs) is accelerated during glycemic and oxidative stress and is an important predictor of complications in diabetes mellitus (DM). STUDY DESIGN: Here we both review and present original data on the relationship between skin autofluorescence (SAF), a noninvasive measure of AGEs, and short- and intermediate-term glycemic variations. RESULTS: Acute changes in glucose levels during an oral glucose tolerance test in 56 persons with varying degrees of glucose tolerance did not influence SAF. AGE-rich meals result in a transient postprandial rise in SAF of 10% 2-4 h later. This could not be attributed to meal-induced glycemic changes and is probably caused by the AGE content of the meal. In type 1 DM major intermediate-term improvements of glycemic control as depicted by multiple hemoglobin A1c (HbA1c) measurements were associated with lower skin AGE levels. In a well-controlled, stable type 2 DM cohort, only a weak correlation was found between SAF and HbA1c. In both studies skin AGE/SAF levels predicted complications of diabetes with an accuracy superior to that of HbA1c. SAF has also been proposed as a new tool in diagnosing impaired glucose tolerance (IGT) and DM. It proved to be more sensitive than either fasting glucose or HbA1c. CONCLUSIONS: SAF is not influenced by short-term glycemic variations. AGE-rich meals may, however, cause a transient rise postprandially. There is a weak correlation between SAF or skin AGEs and current or time-integrated HbA1c levels. SAF has strong added value in risk prediction of complications of diabetes and is a promising tool for early detection of diabetes and IGT.
BACKGROUND: Accumulation of advanced glycation end products (AGEs) is accelerated during glycemic and oxidative stress and is an important predictor of complications in diabetes mellitus (DM). STUDY DESIGN: Here we both review and present original data on the relationship between skin autofluorescence (SAF), a noninvasive measure of AGEs, and short- and intermediate-term glycemic variations. RESULTS: Acute changes in glucose levels during an oral glucose tolerance test in 56 persons with varying degrees of glucose tolerance did not influence SAF. AGE-rich meals result in a transient postprandial rise in SAF of 10% 2-4 h later. This could not be attributed to meal-induced glycemic changes and is probably caused by the AGE content of the meal. In type 1 DM major intermediate-term improvements of glycemic control as depicted by multiple hemoglobin A1c (HbA1c) measurements were associated with lower skin AGE levels. In a well-controlled, stable type 2 DM cohort, only a weak correlation was found between SAF and HbA1c. In both studies skin AGE/SAF levels predicted complications of diabetes with an accuracy superior to that of HbA1c. SAF has also been proposed as a new tool in diagnosing impaired glucose tolerance (IGT) and DM. It proved to be more sensitive than either fasting glucose or HbA1c. CONCLUSIONS:SAF is not influenced by short-term glycemic variations. AGE-rich meals may, however, cause a transient rise postprandially. There is a weak correlation between SAF or skin AGEs and current or time-integrated HbA1c levels. SAF has strong added value in risk prediction of complications of diabetes and is a promising tool for early detection of diabetes and IGT.
Authors: Dania L Felipe; James M Hempe; Shuqian Liu; Nate Matter; John Maynard; Carmen Linares; Stuart A Chalew Journal: Diabetes Care Date: 2011-06-02 Impact factor: 19.112
Authors: Marjon J Noordzij; Joop D Lefrandt; Erik A H Loeffen; Ben R Saleem; Robbert Meerwaldt; Helen L Lutgers; Andries J Smit; Clark J Zeebregts Journal: Int J Cardiovasc Imaging Date: 2011-02-19 Impact factor: 2.357
Authors: C Blanc-Bisson; F L Velayoudom-Cephise; A Cougnard-Gregoire; C Helmer; K Rajaobelina; C Delcourt; L Alexandre; L Blanco; K Mohammedi; M Monlun; V Rigalleau Journal: Cardiovasc Diabetol Date: 2018-06-08 Impact factor: 9.951
Authors: Saskia Corine van de Zande; Jeroen Klaas de Vries; Inge van den Akker-Scheek; Johannes Zwerver; Andries Jan Smit Journal: J Sport Health Sci Date: 2020-09-26 Impact factor: 13.077